Correlation Between PolyPid and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both PolyPid and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PolyPid and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PolyPid and X4 Pharmaceuticals, you can compare the effects of market volatilities on PolyPid and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PolyPid with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PolyPid and X4 Pharmaceuticals.
Diversification Opportunities for PolyPid and X4 Pharmaceuticals
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between PolyPid and XFOR is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding PolyPid and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and PolyPid is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PolyPid are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of PolyPid i.e., PolyPid and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between PolyPid and X4 Pharmaceuticals
Given the investment horizon of 90 days PolyPid is expected to generate 0.2 times more return on investment than X4 Pharmaceuticals. However, PolyPid is 5.02 times less risky than X4 Pharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 342.00 in PolyPid on August 29, 2024 and sell it today you would earn a total of 9.00 from holding PolyPid or generate 2.63% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
PolyPid vs. X4 Pharmaceuticals
Performance |
| Timeline |
| PolyPid |
| X4 Pharmaceuticals |
PolyPid and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with PolyPid and X4 Pharmaceuticals
The main advantage of trading using opposite PolyPid and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PolyPid position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.The idea behind PolyPid and X4 Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals | X4 Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |